Navigation Links
AxoGen, Inc. Announces Presentation of Avance® Nerve Graft Data at American Society for Peripheral Nerve & American Society for Reconstructive Microsurgery 2013 Meetings
Date:1/11/2013

Alachua, FL (PRWEB) January 11, 2013

AxoGen, Inc. (OTCBB: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, announced today that Avance® Nerve Graft, a processed nerve allograft for surgical repair and reconstruction of peripheral nerve segmental defects, will be featured in multiple presentations at The American Society for Peripheral Nerves (ASPN) and The American Society for Reconstructive Microsurgery (ASRM) 2013 Annual Meetings, January 12-15 in Naples, Florida. In addition, AxoGen will be exhibiting its products at Booth 42 throughout the duration of the meetings.

“We are very excited about the increasing interest from the surgeon community,” said Jill Schiaparelli, Senior Vice President of Business Strategy and Marketing for AxoGen. “We are pleased to have several clinical experts in nerve repair presenting data on Avance® Nerve Graft.”

Avance® Nerve Graft is processed nerve allograft intended for the reconstruction of peripheral nerve discontinuities to support axon regeneration across the gap and provides surgeons a readily available nerve graft to repair peripheral nerves damaged by traumatic injury or removed during a surgical procedure.

Presentations on clinical experience with Avance® Nerve Graft at the ASPN and ASRM meetings include:

“Comparisons of Functional Recovery Outcomes with increasingly Rigorous Threshold Parameters from a Multicenter Registry Study of Processed Nerve Allografts,” by RANGER® Registry investigator Gregory Buncke, MD of The Buncke Clinic, January 12, 2013, 4:30-5:30 pm

“Quantitative Outcomes from a Multicenter Registry Study of Processed Nerve Allografts in Sensory and Mixed Repairs Presenting with Concomitant injuries,” by RANGER® Registry investigator Wesley Thayer, MD, PhD, Vanderbilt University, Torso and Trunk Session, January 14, 2013, 2:15-3:30 pm

About AxoGen, Inc.
AxoGen (OTCBB: AXGN) is a leading regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions. AxoGen’s products offer a full suite of surgical nerve reconstruction solutions including Avance® Nerve Graft, the only commercially available processed nerve allograft for bridging severed nerves, AxoGuard® Nerve Connector, a coaptation aid allowing for close approximation of severed nerves, and AxoGuard® Nerve Protector, a bioscaffold used to reinforce a coaptation site, wrap a partially severed nerve or isolate and protect nerve tissue.

The RANGER® Registry is sponsored by AxoGen with nominal funding provided to each center to support the data collection process. All data analysis is handled by an independent biostatistician and no surgeon is compensated for implanting Avance® Nerve Graft.
For more information, visit our website at http://www.axogeninc.com.

Cautionary Statements Concerning Forward-Looking Statements
This Press Release contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management’s current expectations or predictions of future conditions, events or results based on various assumptions and management’s estimates of trends and economic factors in the markets in which we are active, as well as our business plans. Words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “seeks”, “estimates”, “projects”, “forecasts”, “may”, “should”, variations of such words and similar expressions are intended to identify such forward-looking statements. The forward-looking statements may include, without limitation, statements regarding product development, product potential or financial performance. The forward-looking statements are subject to risks and uncertainties, which may cause results to differ materially from those set forth in the statements. Forward-looking statements in this release should be evaluated together with the many uncertainties that affect AxoGen’s business and its market, particularly those discussed in the risk factors and cautionary statements in AxoGen’s filings with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those projected. The forward-looking statements are representative only as of the date they are made, and AxoGen assumes no responsibility to update any forward-looking statements, whether as a result of new information, future events or otherwise.

To receive email alerts directly from AxoGen, please click here http://www.axogeninc.com/emailalerts.html.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10313599.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. AxoGen, Inc. to sponsor Educational Symposium and Panel Discussion at 2013 Annual Meetings of American Association for Hand Surgery, American Society for Peripheral Nerve, and American Society for Reconstructive Microsurgery
2. AxoGen, Inc. Announces Presentation of Avance® Nerve Graft Data at American Association for Hand Surgery 2013 Annual Meeting
3. AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards
4. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
5. University of Houston Graduate College of Social Work announces partnership with MD Anderson
6. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
7. AGA announces prestigious awards recognition recipients
8. TheBestHeartRateMonitorReviews.com Announces The Top 3 Heart Rate Monitors
9. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
10. Zane Benefits Announces Wellness HRAs: A New Way to Reward Healthy Employees
11. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... ... 2016 , ... National recruitment firm Slone Partners is pleased to ... genomics experience, as Vice President of North American Capital Sales at HTG Molecular ... the sales team in the commercialization of the HTG EdgeSeq system and associated reagents ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
Breaking Medicine Technology: